LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | AZD 5438 | 0.04 | uM | LJP6 | 3 | J06 | 72 | hr | 2543 | 5448 | 5578 | 0.9766 | 0.9570 |
| SK-BR-3 | AZD8055 | 0.04 | uM | LJP6 | 2 | A12 | 72 | hr | 2543 | 2177 | 5578 | 0.3902 | -0.1207 |
| SK-BR-3 | Alvocidib | 0.04 | uM | LJP6 | 1 | A18 | 72 | hr | 2543 | 2738 | 5578 | 0.4908 | 0.0641 |
| SK-BR-3 | AZD 5438 | 0.04 | uM | LJP6 | 2 | J06 | 72 | hr | 2543 | 4743 | 5578 | 0.8502 | 0.7247 |
| SK-BR-3 | AZD7762 | 0.04 | uM | LJP6 | 1 | L06 | 72 | hr | 2543 | 1960 | 5578 | 0.3513 | -0.1922 |
| SK-BR-3 | AZD8055 | 0.04 | uM | LJP6 | 1 | A12 | 72 | hr | 2543 | 1946 | 5578 | 0.3488 | -0.1968 |
| SK-BR-3 | Afatinib | 0.04 | uM | LJP6 | 3 | G24 | 72 | hr | 2543 | 1573 | 5578 | 0.2820 | -0.3197 |
| SK-BR-3 | Sigma A6730 | 0.04 | uM | LJP5 | 3 | B24 | 72 | hr | 2543 | 4913 | 5578 | 0.8807 | 0.7807 |
| SK-BR-3 | AT-7519 | 0.04 | uM | LJP6 | 1 | K06 | 72 | hr | 2543 | 5098 | 5578 | 0.9138 | 0.8416 |
| SK-BR-3 | AZD 5438 | 0.04 | uM | LJP6 | 1 | J06 | 72 | hr | 2543 | 4991 | 5578 | 0.8947 | 0.8064 |
| SK-BR-3 | AZD-6482 | 0.04 | uM | LJP5 | 2 | I06 | 72 | hr | 2543 | 5285 | 5578 | 0.9474 | 0.9033 |
| SK-BR-3 | AZD-6482 | 0.04 | uM | LJP5 | 3 | I06 | 72 | hr | 2543 | 5712 | 5578 | 1.0239 | 1.0439 |
| SK-BR-3 | AZD7762 | 0.04 | uM | LJP6 | 2 | L06 | 72 | hr | 2543 | 2117 | 5578 | 0.3795 | -0.1405 |
| SK-BR-3 | AZD7762 | 0.04 | uM | LJP6 | 3 | L06 | 72 | hr | 2543 | 2013 | 5578 | 0.3608 | -0.1748 |
| SK-BR-3 | Afatinib | 0.04 | uM | LJP6 | 1 | G24 | 72 | hr | 2543 | 1649 | 5578 | 0.2956 | -0.2947 |
| SK-BR-3 | Afatinib | 0.04 | uM | LJP6 | 2 | G24 | 72 | hr | 2543 | 1387 | 5578 | 0.2486 | -0.3810 |
| SK-BR-3 | Sigma A6730 | 0.04 | uM | LJP5 | 1 | B24 | 72 | hr | 2543 | 4019 | 5578 | 0.7204 | 0.4861 |
| SK-BR-3 | Sigma A6730 | 0.04 | uM | LJP5 | 2 | B24 | 72 | hr | 2543 | 4282 | 5578 | 0.7676 | 0.5728 |
| SK-BR-3 | Alvocidib | 0.04 | uM | LJP6 | 2 | A18 | 72 | hr | 2543 | 3164 | 5578 | 0.5672 | 0.2045 |
| SK-BR-3 | Alvocidib | 0.04 | uM | LJP6 | 3 | A18 | 72 | hr | 2543 | 2956 | 5578 | 0.5299 | 0.1359 |
| SK-BR-3 | AT-7519 | 0.04 | uM | LJP6 | 2 | K06 | 72 | hr | 2543 | 5162 | 5578 | 0.9253 | 0.8627 |
| SK-BR-3 | AT-7519 | 0.04 | uM | LJP6 | 3 | K06 | 72 | hr | 2543 | 5161 | 5578 | 0.9251 | 0.8624 |
| SK-BR-3 | AZD-6482 | 0.04 | uM | LJP5 | 1 | I06 | 72 | hr | 2543 | 6023 | 5578 | 1.0796 | 1.1464 |
| SK-BR-3 | AZD8330 | 0.04 | uM | LJP5 | 1 | G24 | 72 | hr | 2543 | 3984 | 5578 | 0.7142 | 0.4746 |
| SK-BR-3 | AZD8055 | 0.04 | uM | LJP6 | 3 | A12 | 72 | hr | 2543 | 1916 | 5578 | 0.3435 | -0.2067 |